Background: EhCaBP1 is one of the EF-hand calcium-binding proteins (CaBP) involved in various Ca 2ϩ signaling pathways. Results: Hydrophobic residues at the Ϫ4 position of the Ca 2ϩ -binding loop affects structure, Ca 2ϩ -binding properties, and cellular localization of EhCaBP1. Conclusion: The Y81F mutation in EhCaBP1 makes it more structured like CaM and TnC. Significance: Observed variations in the structures and cellular localization of the wt and mutant could have influence on their biological behavior.
The EF-hand motif (helix-loop-helix) is one of the most common structural motifs found in many genomes and the EF-hand Ca 2ϩ -binding proteins (EF-CaBPs) 2 are distributed throughout cells. These EF-CaBPs regulate diverse cellular targets and there is very little understanding of how a particular sequence of EF-CaBP is involved in any cellular process (1) (2) (3) (4) (5) . Genome analysis revealed that the protist parasite Entamoeba histolytica encodes 27 EF-hand Ca 2ϩ -binding proteins (CaBPs) (7) . The presence of such a large number of CaBPs in this organism suggests that E. histolytica has an intricate and extensive Ca 2ϩ signaling system. Three of these proteins: EhCaBP1 (PDB code 1jfk) (8) , EhCaBP2 (PDB code 2jnx) (9) and EhCaM (PDB code 2lc5) (10) have been structurally characterized by NMR in our laboratory and were shown to have unique individual properties. EhCaBP1 has been studied more extensively and its role in phagocytosis has been deciphered (8, 10 -12) .
Many of the CaBPs present in E. histolytica have four EFhand motifs, but none of these exhibit high sequence identity with calmodulin (CaM) (8 -10, 13, 14) . EhCaBP1 (14.8 kDa) is the first Ca 2ϩ -binding protein identified and structurally characterized from E. histolytica (8) . The structure of EhCaBP1 consists of two domains separated by a linker and each domain consists of two EF-hand motifs (8, 14) . Hydrophobic pockets are created upon binding to Ca 2ϩ , which are the target binding sites for the proteins, and are important for parasite biology. Recent studies revealed that the two domains of EhCaBP1 are functionally and structurally different from each other (15, 16) but both domains are required for structural stability and a full range of functional diversity (17) . Although there is low sequence identity between EhCaBP1 and CaM, the structural topology of EhCaBP1 is similar to that of CaM (PDB code 1cll) and troponin C (TnC; PDB code 2jnf) (8) . Furthermore, it is found to be functionally different from CaM as it binds to a different set of proteins compared with CaM (18) . Ca 2ϩ -binding ability of CaBPs is mostly controlled by the canonical Ca 2ϩ -binding loops with very high sequence homol-* This work was supported by the Tata Institute of Fundamental Research ogy. The loop consists of a contiguous stretch of 12 amino acid residues and binds to Ca 2ϩ in a pentagonal-bipyramidal geometry (19) . The residues in the loop at positions ϩ1, ϩ3, ϩ5, ϩ7, ϩ9, and ϩ12 coordinate with Ca 2ϩ . In addition, the Ca 2ϩ -binding affinity is controlled by other factors such as intrinsic binding affinity of each binding loop, conformational cost upon Ca 2ϩ binding (20, 21) , EF-␤-scaffold etc. Thus, despite the presence of highly conserved residues in the primary sequence of Ca 2ϩ -binding loops, a wide range of Ca 2ϩ -binding affinities were observed in different EF-CaBPs (22) .
The inter-domain linker of EhCaBP1 is more flexible compared with that of CaM and TnC due to the presence of 3 Gly residues in the linker region and thus EhCaBP1 shows different target specificity compared with CaM and TnC (8) . In addition, the hydrophobic packing, inside the core of the protein, may also influence the target specificity of EhCaBP1. A closer examination of the NMR structure revealed that the N-terminal domain is structurally more rigid compared with its C-terminal counterpart (8, 15, 16 89 , and Glu 96 ) in the EF III binding loop as opposed to the presence of only three such residues in rest of the loops (I, II, and IV) or due to the structural differences between the N-and C-terminal domains. Furthermore, based on the amino acid sequence analysis of EhCaBP1, it was reported that the Tyr residue at the Ϫ4th position (Tyr 81 ) of the third Ca 2ϩ -binding loop (instead of a highly conserved Phe residue seen at this position in CaM and TnC) could be the cause of preferential Ca 2ϩ displacement from EF-hand III (20, 21) . Previously, it has been shown that, in a given domain containing a pair of EFhands, highly conserved Phe at the Ϫ4th position in the EF I (F[Ϫ4]) interacts with another highly conserved Phe at the 13th position in the EF II (Phe[ϩ13]) of the same domain such that their respective aromatic rings are oriented perpendicular to one another. Such an orientation results in a shorter C ␣ -C ␣ distance of 7-8 Å (8, 20) . Furthermore, proteins that lack such Phe(Ϫ4)-Phe(ϩ13) interactions are found to have a lower affinity for Ca 2ϩ (23) . Such a Phe-Phe interaction, which is present in both CaM and TnC and also in the N-terminal domain of EhCaBP1, is absent in the C-terminal domain of EhCaBP1 due to the presence of Tyr at the Ϫ4th position (Tyr 81 ) instead of the highly conserved Phe residue. Furthermore, the aromatic rings of Tyr (Ϫ4) and Phe (ϩ13) of the C-terminal domain are oriented parallel to each other with an effective C ␣ -C ␣ distance of 10 -12 Å (20) . This was attributed as one of the reasons for the structural variation of EhCaBP1 from CaM, TnC, and other CaBPs of its family. Against this backdrop, we set out to mutate, Tyr 81 to Phe 81 , in EhCaBP1 at the Ϫ4th position of EF III (Y81F). This mutant, (Y81F)-EhCaBP1, was overexpressed, purified, and the three-dimensional structure characterized both by multidimensional NMR and MD simulation to study the overall structural stability, dynamics, Ca 2ϩ binding properties, in vivo localization, and interaction with G-and F-actin, compared with the wild-type protein (wt-EhCaBP1).
EXPERIMENTAL PROCEDURES
Generation of (Y81F)-EhCaBP1-The (Y81F)-EhCaBP1 mutant was generated using a site-directed mutagenesis kit (Stratagene, La Jolla, CA). The primers used were the following: (Y81F)-EhCaBP1-F, 5Ј-GATTGAAAGTACTCTTTAAACT-TATGGATG-3Ј and (Y81F)-EhCaBP1-R, 5Ј-CATCCATAAG-TTTAAAGAGTACTTTCAATC-3Ј. The protocol followed was as described by the manufacturer. The mutation was confirmed by sequencing. The cDNA encoding (Y81F)-EhCaBP1 was cloned into a pET30a expression vector and transformed into Escherichia coli strain BL21(DE3)pLysS cells.
Protein Expression and Purification-Overexpression and purification of the recombinant protein was carried out as described earlier (14) . Apo-form of wt-and (Y81F)-EhCaBP1 were prepared by buffer exchange in a Centricon ultrafiltration system with a 3-kDa cut-off membrane.
Growth and Maintenance of Parasites-E. histolytica strain HM-1 IMSS and all transformed parasites were maintained and grown in TYI-S-33 medium containing 250 units ml Ϫ1 of benzyl penicillin and 0.25 mg ml Ϫ1 of streptomycin in 100 ml of medium. Cells carrying constructs with a constitutive expression system were maintained at 10 g ml Ϫ1 of G418. However, the in vivo experiments were carried out in the presence of 30 g ml Ϫ1 of G418.
Transfection and Selection of E. histolytica Trophozoites-
Transfection was performed by electroporation. Briefly, trophozoites in log phase were harvested and washed with phosphate-buffered saline (PBS), followed by an incomplete cytomix buffer (10 mM K 2 HPO 4 /KH 2 PO 4 , pH 7.6, 120 mM KCl, 0.15 mM CaCl 2 , 25 mM HEPES, pH 7.4, 2 mM EGTA, 5 mM MgCl 2 ). The washed cells were then re-suspended in 0.8 ml of complete cytomix buffer (incomplete cytomix buffer containing 4 mM adenosine triphosphate, 10 mM glutathione). Plasmid DNA (200 mg) was added to the cell suspension and subjected to two consecutive pulses of 3000 V/cm (1.2 kV) at 25 mF (Bio-Rad, electroporator). The transfectants were initially allowed to grow without any selection. Drug selection was initiated after 2 days of transfection in the presence of 10 g ml Ϫ1 of G-418. Immunofluorescence Staining-Immunofluorescence staining was carried out as described before (11, 12) . Briefly E. histolytica cells resuspended in TYI-33 medium were transferred onto (acetone-cleaned) coverslips placed in a Petri dish and allowed to adhere for 10 min at 35.5°C. The culture medium was removed and cells were fixed with 3.7% pre-warmed paraformaldehyde for 30 min. After fixation, the cells were permeabilized with 0.1% Triton X-100/PBS for 1 min. This step was omitted for non-permeabilized cells. The fixed cells were then washed with PBS and quenched for 30 min in PBS containing 50 mM NH 4 Cl. The coverslips with trophozoites were blocked with 1% BSA/PBS for 30 min followed by incubation with primary antibody. Rabbit polyclonal anti-EhCaBP1 at 1:100, anti-HA at 1:50, and TRITC-Phalloidin at 1:250 was at 37°C for 1 h. The coverslips were washed with PBS and 1% BSA/PBS before incubation with 1:300 diluted anti-rabbit Alexa 488 (Molecular Probes) for 30 min at 37°C. The coverslips with trophozoite cells were further washed with PBS and mounted on a glass slide using DABCO (1,4-diazbicyclo(2,2,2)octane (Sigma) 10 mg/ml in 80% glycerol). The edges of the coverslip were sealed with nail polish to avoid drying. Confocal images were obtained using an Olympus Fluoview FV1000 laser scanning microscope.
Preparation of Cytosolic and Membrane Fraction-To separate membrane proteins from the cytoplasmic fraction, the cell extract was prepared by resuspending the cell pellet (ϳ10 7 , washed with PBS) in 1 ml of 100 mM Na 2 HPO 4 buffer containing protease inhibitors (10 mM N-ethylmaleimide, 2 mM PMSF, 0.01 mM leupeptin, and 2 mM 4-(hydroxymercuri)benzoic acid). The suspension was then subjected to three cycles of freezethawing followed by centrifugation at 100,000 ϫ g for 30 min at 4°C. The resulting supernatant was labeled as the cytoplasmic fraction and the pellet as the membrane fraction. The pellet was washed twice with the above buffer and resuspended in the same buffer containing 1% Triton X-100 and re-centrifuged at 100,000 ϫ g for 20 min at 4°C, to separate the Triton-soluble fraction from Triton-insoluble fraction. The protein content of each fraction was estimated by BCA assay. The Triton-soluble fraction was further taken for analysis.
Circular Dichroism (CD)-CD spectra of wt-and (Y81F)-EhCaBP1 were recorded on a JASCO J-810 spectropolarimeter equipped with a Peltier temperature controller. A protein solution of 20 M was used for far-UV CD spectra. The temperature dependence of the CD spectra was carried out to determine the thermal stability of the mutant protein.
Dynamic Light Scattering-The hydrodynamic radius (R H ) was determined for (Y81F)-EhCaBP1 and wt-EhCaBP1 using the dynamic light scattering method on Dynapro-LS instrument at 830 nm. The protein samples were centrifuged at 13,000 ϫ g for 10 min and filtered through a 0.45-m syringe filter from Millipore into a quartz cuvette. A protein concentration of 8 mg/ml was used for each measurement. Of 50 to 60 measurements, only those showing a parabolic curve with a straight base line were considered for mean Ϯ S.D. calculation. The R H was thus determined from the regularization plot.
Isothermal Titration Calorimetry (ITC)-ITC experiments with (Y81F)-EhCaBP1 were performed with a Microcal VP-ITC titration calorimeter at 25°C. Apo-(Y81F)-EhCaBP1 was prepared by EGTA, EDTA, and Chelex-100 treatment, centrifuged, and degassed prior to the titration with Ca 2ϩ . Each titration consisted of injecting 3-l aliquots of 10 mM Ca 2ϩ solution (diluted from 1 M standard CaCl 2 solution purchased from Sigma) into 200 M protein solution (1.7 ml) at an interval of 3 min, to ensure that the titration peak returned to the base line prior to the following injection. The ITC data thus obtained was base line corrected and analyzed using the software ORIGIN, supplied with the instrument. The amount of heat released per addition of the titrant was fitted to different models to determine the number of binding sites and the metal binding affinities of the protein. (26, 28) and prior knowledge of the resonance assignments of wild-type protein (26) , using the root mean square deviation-based algorithm discussed earlier (27) . Furthermore, such assignments were verified by using other multidimensional NMR data (28 -32) . The resonance assignments thus obtained were The 15 N relaxation data measurements were carried out on 800 MHz NMR spectrometer at 25°C with both wt-and (Y81F)-EhCaBP1 to see the effect of the point mutation (Y81F) on its dynamics. The 15 N spin-lattice relaxation rates (R 1 ϭ 1/T 1 ) were measured with inversion recovery delays of 50, 100, 200*, 300, 400, 500, 600*, and 800 ms. The 15 N spin-spin relaxation rates (R 2 ϭ 1/T 2 ) were measured with Carr-Purcell-Meiboom-Gill delays of 10*, 30, 50*, 70, 90, 110*, 130, 150, 170, and 190 ms. The uncertainty in the peak heights was determined in the duplicate spectra recorded with relaxation delays (marked with an asterisk) (33, 34) . The number of scans was set to 32. Phenomenological R 1 and R 2 values and corresponding uncertainties were determined by non-linear least-square fitting of the experimental data to single exponentials. The [ 15 N, 1 H]-NOE spectra were recorded with and without proton saturation during relaxation delay, with 64 scans for each complex t 1 point on both wt-and (Y81F)-EhCaBP1. A 2.5-s period of proton saturation was used in the NOE experiment.
Molecular Dynamics (MD) Simulation-MD simulations were performed on both wt-and (Y81F)-EhCaBP1 using GROMACS molecular modeling package (version 4.0.7) (35) and GROMOS96 (ffG43a1) force-field (36, 37) with explicit simple point charge solvent (38) . The starting structure for wild-type protein in its holo-form was the lowest-energy NMR structure of EhCaBP1 reported earlier (PDB code 1jfk) (8) . As for the simulation of [Ca 2ϩ ] 4 -(Y81F)-EhCaBP1, the starting structure was constructed by mutating Tyr 81 to Phe 81 in the above mentioned wild-type protein structure using PyMOL (39). Simulations were performed with cubic periodic boundary under constant volume and temperature (NVT) conditions. Addition of two Na ϩ neutralized the total charge of the system. The electrostatic interactions were treated by the particle mesh Ewald method with Coulomb cut-off of 1 nm. The van der Waals interactions were treated using Lennard-Jones potential with a cut-off distance of 1 nm and a switching distance of 0.9 nm. Initially, the starting structures of (Y81F)-EhCaBP1 and wt-EhCaBP1 were subjected to energy minimization to remove van der Waals contacts of high potential energy using the steepest descent algorithm with a tolerance of 100 kJ mol Ϫ1 nm
Ϫ1
and convergence was obtained in both cases. Following this, the position restrained MD were performed for 50 ps to equilibrate the solvent in and around the protein during which atomic positions of the proteins were restrained. Initial velocities were generated conforming to the Maxwell velocity distribution at 27°C. Subsequently, MD simulations were initiated by integrating the Newtonian equations of motion with a time step of 2 fs. All bonds were constrained using LINCS algorithm. Coordinates were saved every 1,000 steps (2 ps) for the analysis and corresponding velocities were saved every 10,000 steps (20 ps) for continuing the simulation. The temperature of the simulated system was maintained at 27°C by coupling to the Berendsen thermostat at a time constant of 0.1 ps, where the protein and solvent along with ions were coupled separately to the temperature bath. The MD simulations were unbiased and unconstrained. They were performed for a reasonable length of time (10 ns each). The simulation protocol was adopted following earlier work (40) . Analyses were performed using the tools provided by the GROMACS software package, PyMOL (39), VMD ( . The remaining activated groups on the chip, which did not react with the G-actin, were blocked by an injection of 50 l of 1 mol/liter of ethanolamine solution. The wt and mutant proteins (0.5 mg/ml) and their apo-forms were taken in corresponding buffers (20 mM Tris-Cl, 10 mM CaCl 2 , and 150 mM NaCl for holo-form and 20 mM Tris-Cl, 5 mM EGTA, and 150 mM NaCl for apo-form) and were allowed to bind to the immobilized G-actin for a time span of 1 h at a flow rate of 15 l s Ϫ1 . The binding was monitored from the angular shift.
Solid-phase Assay-The solid-phase assay experiments were performed to monitor the binding of wt-and (Y81F)-EhCaBP1 to G-actin. The wells of the ELISA plate were coated with 5 M G-actin in PBS buffer and incubated for 12 h at 4°C. The wells were washed with BPS-T buffer. The wt-and (Y81F)-EhCaBP1 protein of 5 M each was added to the wells in duplicates. Bound protein was detected with anti-EhCaBP1 antibody followed by horseradish peroxidase-linked anti-rabbit IgG using the colorimetric substrate 3,3Ј,5,5Ј-tetramethylbenzidine (Sigma). The reaction was stopped with 2 N H 2 SO 4 and absorbance was monitored at 405 nm with ELISA plate reader (Bio-Rad).
Co-sedimentation Assay-Co-sedimentation assay was carried out for monitoring binding of wt-and (Y81F)-EhCaBP1 with F-actin, following the protocol published earlier (11) . Briefly, 5 M rabbit muscle G-actin (Sigma) was polymerized for 60 min in polymerization buffer containing 100 mM KCl and 2 mM MgCl 2 at room temperature. After polymerization, actin was mixed with 1 mM ATP and the appropriate target protein (5 M) in a total volume of 150 l of G-buffer (10 mM Tris-Cl, pH 7.5, 2 mM CaCl 2 , 2.5 mM ␤-mercaptoethanol, 0.5 M KCl, 10 mM MgCl 2 ) and incubated for 2 h at room temperature. The samples were centrifuged at 100,000 ϫ g for 45 min at 25°C, which favor F-actin formation. The supernatant (one-fourth of total) and pellet fractions (total) were analyzed by 12% SDS-PAGE, followed by Coomassie Blue staining. All target proteins were ultracentrifuged at 100,000 ϫ g for 1 h and the supernatant was used prior to the above assay to avoid detection of any spurious aggregate(s).
RESULTS AND DISCUSSION
(Y81F)-EhCaBP1 Is a Stable Monomer-The recombinant mutant protein was purified and analyzed by SDS-PAGE, mass spectrometry (MALDI), and dynamic light scattering. The protein essentially shows a single band in SDS-PAGE (supplemental Fig. S1A ), indicative of its purity. The MALDI data clearly shows the purity and monomeric state of the protein, similar to that of EhCaBP1 (supplemental Fig. S1B ). The molecular masses of (Y81F)-EhCaBP1 and the wild-type proteins are 14.806 and 14.822 kDa, respectively (supplemental Fig. S1B ), as determined by MALDI. The dynamic light scattering measurements also reveal the monomeric form for both wt-and (Y81F)-EhCaBP1 (supplemental Fig. S2 ). The hydrodynamic radii determined by the dynamic light scatterings were 2.0 and 1.7 nm for the wt-and (Y81F)-EhCaBP1, respectively. The far-UV CD spectra recorded with both the wt-and (Y81F)-EhCaBP1 show a similar percentage of secondary structural components (supplemental Table S3 and Fig. S3 ). The temperature-dependent far-UV CD spectra show high stability for both the wt-and (Y81F)-EhCaBP1 (supplemental Fig. S3 ).
Ca
2ϩ -binding Affinity of the Mutant-Ca 2ϩ -binding affinity and associated thermodynamic parameters were reported earlier for wt-EhCaBP1 using both NMR and ITC (13) . Although four metal ions have been shown to bind wt-EhCaBP1, detailed analysis revealed that three sites bind Ca 2ϩ in an exothermic manner, whereas one site in an endothermic manner. The latter is thought to be due to weak a Ca 2ϩ -binding affinity of the fourth Ca 2ϩ -binding site. The data could be fitted to only a sequential four-site model and the overall dissociation constant was reported to be 3.16 M (13). , as confirmed by the observation of four downfield shifted spectral signatures of the Gly residues ( Fig. 1A and supplemental Fig. S4 ) in the two-dimensional [ 15 N, 1 H]-HSQC. The Ca 2ϩ binding process is completely exothermic in nature for all the four sites of (Y81F)-EhCaBP1, unlike wild-type protein. The ITC data could be fitted to only two sets of sites model and overall dissociation constant was found to be 86 nM (Table 1 ). This shows a substantial enhancement in the Ca 2ϩ -binding affinity due to the point mutation, similar to the one observed in the case of a 36-residue long peptide representing the EF III of the protein with Tyr to Phe mutation (23) . To explain this enhanced affinity, the factors that determine the intrinsic Ca 2ϩ -binding affinity need to be considered. The major controlling factors are the changes in enthalpy (⌬H) and entropy (⌬S). Among these two, the enthalpic contribution to the affinity in a favorable manner is in the formation of constructive electrostatic interactions between the ligands and the metal ion. In addition, loop-based helix-dipole and inter-helical interactions also play key roles in the binding enthalpy. The entropic contribution to the affinity in a favorable manner arises from the release of water molecules from the coordination sphere of the metal ion to the bulk solvent, when Ca 2ϩ coordinates to the protein, thus increasing the overall Ca 2ϩ -binding affinity. On the other hand, the factor that contributes to the entropy in an unfavorable manner arises from the loss of conformational entropy due to structural rigidity in the presence of Ca S4 ) of wt-and (Y81F)-EhCaBP1 revealed significant chemical shift perturbations for some residues, although the majority of residues did not show any noticeable change in their chemical shifts (Fig. 1B, supplemental Fig. S4) (Fig. 1B) , respectively. As evident in at the mutated site with the residues in the above specified stretches. Such chemical shift perturbations hint at conformational changes in the C-terminal domain, which may result in an altered hydrophobic surface. This is crucial for protein-protein interactions, which in turn controls the function of the protein. It was reported earlier that the N-and C-terminal domains show distinct unfolding behavior and hence are thought to function independently (15) . The small chemical shift changes observed for the residues belonging to the N-terminal domain may be attributed to an altered domain orientation in the mutant protein.
Based on the well known empirical relation of 13 (42, 43) , the secondary structure elements of the mutant protein were characterized. As evident in the Fig.  1C , (Y81F)-EhCaBP1 is predominantly ␣-helical in conformation with 8 ␣-helices and 4 short stretches of ␤-strands, similar to that of the wt-EhCaBP1, indicating that the Y81F point mutation does not alter the secondary structural elements in the protein. This is also evident from the far-UV CD spectra, which show 71 and 74% helical content for wt-and (Y81F)-EhCaBP1, respectively (supplemental Table S3 and Fig. S3) .
Modulation of Conformational Dynamics-The 15 N relaxation study is one of the most established methods for probing millisecond to picosecond motions along the polypeptide backbone (33) . In other words, NMR relaxation measurements provide information about the overall and internal motions in pro- teins, which is crucial for explaining its structural dynamics. On the other hand, although the R 2 values for the (Y81F)-EhCaBP1 (Fig. 2B ) also show variations all along the sequence, the variation was found to be more systematic and significant in the C-terminal domain as compared with that of the wild-type protein. As is evident from Fig. 2B , the R 2 values for the residues in the C-terminal domain of the mutant were found to be significantly higher compared with its counterpart in the wildtype protein, which could be attributed to the rigidity/compactness induced by the point mutation (Fig. 2B) . The mean value of R 2 for N-and C-terminal domains of wt-EhCaBP1 were found to be 13.98 Ϯ 1.19 and 13.03 Ϯ 1.23 s
Ϫ1
, whereas for (Y81F)-EhCaBP1 were 14.08 Ϯ 1.56 and 15.46 Ϯ 1.12 s Ϫ1 , respectively. Furthermore, to probe the differences in the backbone mobility and conformational dynamics, the difference in the residuewise R 2 values between wt-and (Y81F)-EhCaBP1 were calculated (Fig. 2C) . Thus, the -interaction between the aromatic rings of Phe 81 and Phe 129 and the hydrophobic interaction discussed later could result in the C-terminal domain adopting a compact/rigid three-dimensional structure as in the case of CaM and TnC compared with the wt-EhCaBP1. Furthermore, the relative increase in the R 2 /R 1 values (Fig. 2D ) of individual residues for the C-terminal domain in the case of the mutant compared with that of the wild-type protein indicates conformational exchanges induced due to the Y81F mutation. Mean values of R 2 /R 1 for wt-EhCaBP1 were found to be 16.5 Ϯ 0.53 and 13.89 Ϯ 0.46 for the N-and C-terminal domains, respectively, whereas for (Y81F)-EhCaBP1 these values were found to be 16.4 Ϯ 0.74 and 17.4 Ϯ 0.58 for the respective domains (Fig. 2D) .
To substantiate the observed changes in R 2 values upon point mutation, [ 15 N, 1 H]-NOEs were measured for both wt-and (Y81F)-EhCaBP1 (Fig. 2E) as mentioned under "Experimental Procedures." The mean value of NOEs was found to be 0.82 Ϯ 0.07 for the N-terminal domains of both wt-EhCaBP1 and (Y81F)-EhCaBP1, whereas the corresponding values were 0.82 Ϯ 0.02 and 0.89 Ϯ 0.05 for the C-terminal domains of wt-EhCaBP1 and (Y81F)-EhCaBP1, respectively. The increased mean value of NOEs for the C-terminal domain of (Y81F)-EhCaBP1 corroborates the compactness of its three-dimensional structure induced by the point mutation as compared with its wild-type protein. Thus, we propose that the -interaction of the Phe rings (Phe 81 and Phe 129 ) and hydrophobic interaction with other residues in (Y81F)-EhCaBP1 makes its three-dimensional structure more compact, similar to that of CaM and TnC. The relaxation data are further supported by the outcome of MD simulations (Fig. 3) and the NMR-derived three-dimensional structure of (Y81F)-EhCaBP1 (Fig. 4) discussed below.
MD Simulations on wt-and (Y81F)-EhCaBP1
-MD simulations were performed on both wt-and (Y81F)-EhCaBP1 proteins as described under "Experimental Procedures" and various conformational parameters were monitored to assess the changes caused by the point mutation. To start with, the Phe 81 (C ␣ )-Phe 129 (C ␣ ) distance was monitored throughout the simulation (Fig. 3A) . As evident from performed with a focus on the Tyr 81 /Phe 81 -Phe 129 residues belonging to wt-and (Y81F)-EhCaBP1, respectively. Interestingly, we observed four different clusters for the wild-type protein displaying cluster percentages of 34, 19, 16 , and 8% of the total population (Fig. 3B) . On the other hand, a single major cluster with 81% (Fig. 3B) of the total population was observed ) distances of 9.8, 9.0, 9.2, and 9.8 Å, respectively, which are ϳ1 to 2 Å larger than the distance observed in the mutant. Furthermore, it is interesting to note that Phe 81 and Phe 129 in (Y81F)-EhCaBP1 are oriented in an edge-to-face manner suggesting a stronginteraction as seen in CaM and TnC (Fig. 3B) . In wild-type protein simulation, Tyr 81 and Phe 129 residues are far apart in clusters 1 and 4 suggesting the absence of -interaction, whereas in clusters 2 and 3, they show an edge to face interaction with the Phe 81 (C ␣ )-Phe 129 (C ␣ ) distance larger than that seen in the predominant mutant cluster.
We monitored the hydrophobic residues at and around the mutated site in both wild-type and mutant simulations. Fig. S5) . Thus, the number of hydrophobic residues forming the hydrophobic core in the C-terminal domain of the protein is more in the mutant compared with the wild-type protein. Overall, the strong -interaction observed between the two aromatic residues (Phe 81 and Phe
129
) and the large hydrophobic interaction (supplemental Fig. S5 ) present among nine residues facilitate the compactness of the C-terminal domain in the mutant protein similar to that reported for CaM and TnC (20 (Fig. 3C) . This H-bond interaction is energetically more favorable than the expected hydrophobic interaction and -interaction between Tyr 81 and Phe 129 . As a result, the aromatic rings of Tyr 81 and Phe 129 in wt-EhCaBP1 remain away from each other, resulting in an average Tyr 81 (C ␣ )-Phe 129 (C ␣ ) distance of ϳ10 Å (Fig. 3, A and B) . This is likely to be the reason for EF III and IV in the C-terminal domain of wt-EhCaBP1 to adopt open loop conformations compared with their counterparts (EF I and EF II) in the N-terminal domain and diverge from the corresponding loops in CaM and TnC. On the other hand, in the mutant, the mutated residue Phe 81 does not engage in any of the aforementioned H-bonding (Fig. 3C, Scheme 1) . Instead, it involves a stronger hydrophobic interaction as described above. To understand the hydrophobic interaction at and around the mutation site, we monitored the hydrophobic solvent accessible surface area available for Phe 129 , which is a common interacting partner of Tyr 81 /Phe 81 . As expected, the hydrophobic solvent accessible surface areas for Phe 129 in (Y81F)-EhCaBP1 and wt-EhCaBP1 were 5 and 14 Å 2 , respectively (supplemental Fig. S6 ). As mentioned above, Phe 129 is involved in a stronger hydrophobic interaction with nine residues, and this large hydrophobic interaction facilitates the C-terminal domain to be relatively more closed in the mutant. Furthermore, the superposition of Ca 2ϩ -binding loops of EF III and IV of the mutant with wtEhCaBP1, CaM, and TnC revealed that the mutant protein samples loop conformation (supplemental Fig. S7 ) similar to that of CaM and TnC, unlike the wt-EhCaBP1.
NMR Structure Calculation of (Y81F)-EhCaBP1-The threedimensional structure of (Y81F)-EhCaBP1 was determined using (i) dihedral angle constraints ( and ) derived from TALOS using 1 15 N-and 13 Cedited NOESY after identifying and assigning all the NOESY cross-peaks (the lower bound and upper bound distance constraints were set to 2.4 and 6.0 Å, respectively); (iii) H-bond constraints for the residues, which are involved in ␣-helical and ␤-sheet conformation; and (iv) Ca 2ϩ -ligand coordination derived from pseudo-contact shifts. The structure was calculated using CYANA 3.0 (45, 46) , following the standard simulated annealing and torsion angle dynamics protocol. The structures of N-and C-terminal domains of (Y81F)-EhCaBP1 were determined separately (PDB codes 2m7m and 2m7n, respectively; Fig. 4, A and B) . The details of structural statistics are provided in supplemental Tables S1 and S2. The three-dimensional structure of (Y81F) (Fig. 3B) (Fig. 2, A-E can then be used to determine and/or refine/validate the highresolution three-dimensional structure of any given protein under investigation (20, 21 (47) . During the course of titration, a number of changes were noticed in the two-dimensional [ 15 N, 1 H]-HSQC spectrum. During the initial steps of titration, several of the original peaks broadened due to the enhancement of relaxation rates induced by the paramagnetic ion (Yb 3ϩ ), whereas several new peaks appeared all over the HSQC spectrum and several others remained unaffected in their positions and line widths. It is worth mentioning here that when Yb 3ϩ is added to a protein, the cross-peaks of residues undergo pseudo-contact shift if they lie within a distance range of 10 -25 Å of Yb 3ϩ , whereas it is expected to completely broaden out if they are located within 10 Å of Yb 3ϩ and mostly unaffected if they are beyond 25 Å. The pseudo-contact shifts thus arising from the paramagnetic ion provide long-range distance constraints with respect to NOEs FIGURE 5. Binding of (Y81F)-EhCaBP1 to G-actin. In the solid phase assay, the wt-EhCaBP1 and (Y81F)-EhCaBP1 proteins were incubated with G-actin-coated wells of a multiwell plate as described in the text. Binding was carried out either in the presence of Ca 2ϩ or EGTA, as indicated. EhCaBP1 binding was quantified by ELISA using an antibody against EhCaBP1. A, calcium dependence of binding of wt-EhCaBP1 and (Y81F)-EhCaBP1 to G-actin by indirect ELISA. CaBP2 that does not bind actin is used as a negative control (experiment repeated three times; n ϭ 3). B, the co-sedimentation assay was carried out for wt-EhCaBP1, (Y81F)-EhCaBP1, and CaBP2 with F-actin (n ϭ 3). The binding was monitored either in the presence of Ca 2ϩ or EGTA. Y81F mutant protein was found to bind actin filaments in Ca 2ϩ independent manner contrary to that observed for the wt-EhCaBP1 (n ϭ 3). EhCaBP2 was used as a negative control as it is a close homolog of EhCaBP1 (79% identity at amino acid level) and does not bind actin.
and they can be used in calculation, refinement, and validation of high-resolution three-dimensional structures of proteins in solution. It also helps in fixing the position of the metal ions (Ca 2ϩ in CaBPs) and to study their binding motifs, which is important for metal-binding proteins.
During the initial stages of the titration, peaks due to Gly 90 belonging to EF III, broadened out first, whereas the peak due to Gly 122 of EF IV started showing pseudo-contact shift. Thereafter, Gly 51 of EF II broadened and Gly 15 of EF I showed pseudocontact shift. In the later stages of the titration Gly 15 and Gly peaks started broadening out. Thus, Ca 2ϩ displacement by Yb 3ϩ follows a sequential path involving first, the site III followed by sites II, I, and IV, similar to that observed earlier (20, 21) with wt-EhCaBP1 (supplemental Fig. S9) -binding affinity as observed in our ITC measurements described above.
G-actin Binding to wt and Mutant Using SPR-The binding characteristics of G-actin with the wt and mutant proteins were studied in the presence and absence of Ca 2ϩ by SPR experiment. As described under "Experimental Procedures," the gold sensor chip was coated with G-actin and binding with wt and mutant proteins in their apo-and holo-forms were monitored by determining the change in the angular shift. For wtEhCaBP1 protein the angular shifts in the presence and absence of Ca 2ϩ were 24 and 16 mDeg, respectively, whereas for (Y81F)-EhCaBP1 the corresponding values were 29 and 19 mDeg, respectively (supplemental Fig. S10 ). These findings clearly suggest that the wt and mutant proteins display almost similar binding affinity in the presence of Ca 2ϩ and both values decrease upon removal of Ca 2ϩ . Functional Characterization of (Y81F)-EhCaBP1-It is likely that the mutation may disrupt some of the properties of wtEhCaBP1. To check this, we have carried out a few assays based on the property of the wild-type protein. Functional differences such as binding to actin and subcellular localization between (Y81F)-EhCaBP1 and the wild-type were analyzed. In the first assay, G-actin binding was assessed using a solid-phase system described earlier (12, 17) . Both (Y81F)-EhCaBP1 and wtEhCaBP1 bound G-actin almost to the same extent and the binding by both proteins was reduced by about 50% in the absence of Ca 2ϩ (Fig. 5A ). This is in accordance with the SPR results using apo-and holo-forms, described above.
Further binding to F-actin was analyzed by a co-sedimentation assay. In this assay, F-actin was incubated with the indicated protein and sedimented by ultracentrifugation as described under "Experimental Procedures." The presence of the protein substantially more in the pellet as compared with that present in the supernatant suggested the binding to F-actin (Fig. 5B) (11) and the N-terminal domain of EhCaBP1 showed that these did not bind G-actin while retaining their ability to bind F-actin (17) . In the absence of actin both the (Y81F)-EhCaBP1 and wild-type proteins were found only in the supernatant (supplemental Fig. S11 ) confirming that these proteins do not aggregate in the presence of Ca 2ϩ . Because the Y81F mutation has not affected calcium dependence of the (Y81F)-EhCaBP1 protein for binding G-actin, it is possible that mutation rendered interaction with F-actin to be Ca 2ϩ independent but this may be mediated by other mechanisms that led to defective dynamic behavior in vivo.
Subcellular localization of HA-tagged (Y81F)-EhCaBP1 and wt-EhCaBP1 was checked by immunofluorescence staining of transformed trophozoites. HA tagging was used to distinguish the mutant from endogenous proteins. The results are shown in Fig. 6 , where E. histolytica trophozoites were shown to phagocytose RBCs. Actin polymerization and depolymerization is important for phagocytosis and Ca 2ϩ -binding proteins are involved in this process. The wt-EhCaBP1 was found in the cytosol and around the phagocytic cups as reported earlier (11) and also as shown in Fig. 6A . The (Y81F)-EhCaBP1 was found localized more in the plasma membrane instead of the cytosol in normal proliferating cells (Fig. 6B) . Actin is observed around the phagocytic cups and pseudopods. Both actin and wtEhCaBP1 co-localize at these sites. To delineate the localization pattern of (Y81F)-EhCaBP1, trophozoites were stained in the absence of erythrocytes where phagocytosis is not observed. Results (Fig. 6C) show that both actin and (Y81F)-EhCaBP1 proteins were found in the pseudopods. In contrast, only a small fraction of the mutant protein co-localized with actin at the phagocytic cups (Fig. 6, compare D with A) . To validate these observations the levels of fluorescence in cytosol, membrane, and phagocytic cups were quantitated as described (11, 48) and the results clearly showed that (Y81F)-EhCaBP1 is significantly more in the membrane region compared with the cytosol (Fig.  6E) . This was further confirmed by fractionation of cellular compartments and checking the presence of both proteins by Western blot analysis (Fig. 6F) . A significantly higher fraction of (Y81F)-EhCaBP1 was seen in the membrane fraction compared with that in the wild-type protein.
Although actin dynamics play critical roles in both phagocytosis and pseudopod formation, different actin modulating proteins may be required in the two processes (6, 49) . Variation in the localization of the mutant (Y81F)-EhCaBP1 and wild-type For E, five random regions were selected from membrane, cytosol, and phagocytic cups and average relative intensity was computed for each region by taking the signal from membrane as 100%. This was repeated for 10 such cells (n ϭ 10), bars represent standard error; scale bar, 10 m. TRITC-Phalloidin was used to mark actin filaments. EhCaBP1 was probed by specific antibody, HA tag (Y81F)-EhCaBP1 was probed by anti-HA antibody. Furthermore, both proteins were probed by Alexa 488-labeled secondary antibody. F, the distribution of HA tag (Y81F)-EhCaBP1 protein in membrane and cytosolic fractions as compared with EhCaBP1 as seen by Western blotting (Western blotting includes the antibody step, immunostaining is used for microscopy).
EhCaBP1, despite their ability to bind F-actin, is notable. It is probable that other proteins are needed to stabilize EhCaBP1 and F-actin interaction in vivo and that the (Y81F)-EhCaBP1 may not be structurally suitable for interaction with these proteins and hence cannot form a stable complex in vivo although both bind in vitro. This may explain its absence from phagocytic cups. We have also detected (Y81F)-EhCaBP1 in recently formed phagosomes contrary to that of wild-type EhCaBP1 (supplemental Fig. S12A ). The wild-type molecule moves out of the phagocytic cups before the formation of phagosomes (supplemental Fig. S12B ) (11) . Phagocytic cups can still form in cells expressing the mutant proteins. This may be due to continued expression of the wild-type EhCaBP1 from the endogenous gene. We believe that the small fraction of (Y81F)-EhCaBP1 associated with the cups persists in the phagosomes due to the loss of the dynamic property associated with the wild-type protein. The mutant protein remains constitutively associated with plasma membrane and it is that protein that is decorating the newly formed phagosome membrane. Experiments are in progress to understand the molecular mechanisms of some of these processes in detail.
Conclusion-In conclusion, the Y81F mutation in the C-terminal domain of the EF-hand EhCaBP1 makes it more structured and compact as in the case of CaM and TnC. , triggers the C-terminal domain to adopt a compact conformation, similar to that seen in CaM and TnC. Thus, in EF-hand CaBPs, the above mentioned -interaction between the aromatic rings of Phe(Ϫ4) and Phe(ϩ13) within a domain is crucial and such interaction largely dictates its functional activities. Furthermore, G-actin binding assay using a solid-phase system revealed that the mutant protein binds G-actin in a Ca 2ϩ -dependent manner as in the case of wt-EhCaBP1. On the other hand, binding to F-actin showed a differential behavior. Unlike the wild-type protein, the mutant protein binds in a Ca 2ϩ -independent manner. The mutant protein is localized more in the plasma membrane compared with that of the wild-type protein.
Overall, although the mutant retained many of the properties of wild-type protein such as the ability to bind G-and F-actin and recruitment to pseudopods, it also displayed a number of altered characteristics like enhanced association with plasma membrane and Ca 2ϩ independent binding to F-actin and lack of recruitment to the phagocytic cups. We suspect that these variations could have influence on dynamic properties of this protein and hence biological behavior of these molecules.
